Alexandra Y Tsidulko
Overview
Explore the profile of Alexandra Y Tsidulko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sokolov D, Shevelev O, Khotskina A, Tsidulko A, Strokotova A, Kazanskaya G, et al.
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373391
Glioblastoma (GB) is an aggressive cancer with a high probability of recurrence, despite active chemoradiotherapy with temozolomide (TMZ) and dexamethasone (DXM). These systemic drugs affect the glycosylated components of brain...
2.
Politko M, Tsidulko A, Pashkovskaya O, Kuper K, Suhovskih A, Kazanskaya G, et al.
Int J Mol Sci
. 2021 Dec;
22(24).
PMID: 34948147
Intensive adjuvant radiotherapy (RT) is a standard treatment for glioblastoma multiforme (GBM) patients; however, its effect on the normal brain tissue remains unclear. Here, we investigated the short-term effects of...
3.
Tsidulko A, Shevelev O, Khotskina A, Kolpakova M, Suhovskih A, Kazanskaya G, et al.
Front Oncol
. 2021 Aug;
11:713139.
PMID: 34350124
Adjuvant chemotherapy with temozolomide (TMZ) is an intrinsic part of glioblastoma multiforme (GBM) therapy targeted to eliminate residual GBM cells. Despite the intensive treatment, a GBM relapse develops in the...
4.
Politko M, Prokaeva A, Pashkovskaya O, Kuper K, Zheravin A, Kliver E, et al.
Mol Biol Rep
. 2020 Jun;
47(7):5657-5663.
PMID: 32514998
Radiotherapy is an integral part of glioblastoma treatment affecting both cancer cells and tumour microenvironment, where proteoglycans (PGs) are key extracellular components. However, the molecular effects of radiotherapy on PGs...
5.
Suhovskih A, Kazanskaya G, Volkov A, Tsidulko A, Aidagulova S, Grigorieva E
Int J Mol Sci
. 2020 Feb;
21(4).
PMID: 32075104
Adjuvant chemoradiotherapy is a standard treatment option for glioblastoma multiforme (GBM). Despite intensive care, recurrent tumors developed during the first year are fatal for the patients. Possibly contributing to this...
6.
Tsidulko A, Kazanskaya G, Volkov A, Suhovskih A, Kiselev R, Kobozev V, et al.
Cell Tissue Res
. 2019 Nov;
379(1):147-155.
PMID: 31773303
Chondroitin sulfate proteoglycans (CSPGs) are important components of brain extracellular matrix (ECM), although their contribution in gliomagenesis remains underinvestigated. Here, both chondroitin sulfate (CS) content/distribution and expression of a number...
7.
Suhovskih A, Kazanskaya G, Volkov A, Tsidulko A, Aidagulova S, Grigorieva E
Histochem Cell Biol
. 2019 Jun;
152(3):239-247.
PMID: 31197457
Histological and immunohistochemical studies require high-quality paraffin blocks, where proper fixation of tissue samples with formalin is a key point. However, in some cases, the possibility to preserve biological samples...
8.
Tsidulko A, Bezier C, de La Bourdonnaye G, Suhovskih A, Pankova T, Kazanskaya G, et al.
Front Pharmacol
. 2018 Oct;
9:1104.
PMID: 30333749
Temozolomide (TMZ) is a conventional chemotherapy drug for adjuvant treatment of glioblastoma multiforme (GBM), often accompanied by dexamethasone (DXM) to prevent brain oedema and alleviate clinical side effects. Here, we...
9.
Kazanskaya G, Tsidulko A, Volkov A, Kiselev R, Suhovskih A, Kobozev V, et al.
Histochem Cell Biol
. 2018 Jan;
149(3):235-244.
PMID: 29322326
Glycosaminoglycans are major components of brain extracellular matrix (ECM), although heparan sulfate (HS) contribution in brain physiology and carcinogenesis remains underinvestigated. This study examined HS content and distribution in glioblastoma...
10.
Ushakov V, Tsidulko A, de La Bourdonnaye G, Kazanskaya G, Volkov A, Kiselev R, et al.
Int J Mol Sci
. 2017 Nov;
18(11).
PMID: 29104277
Heparan sulfate (HS) is an important component of the extracellular matrix and cell surface, which plays a key role in cell-cell and cell-matrix interactions. Functional activity of HS directly depends...